Invention Grant
US09012453B2 Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
有权
氘化1-哌嗪基-3-苯基茚烷用于治疗精神分裂症
- Patent Title: Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
- Patent Title (中): 氘化1-哌嗪基-3-苯基茚烷用于治疗精神分裂症
-
Application No.: US13924849Application Date: 2013-06-24
-
Publication No.: US09012453B2Publication Date: 2015-04-21
- Inventor: Morten Jorgensen , Peter Hongaard Andersen , Klaus Gjervig Jensen
- Applicant: H. Lundbeck A/S
- Applicant Address: DK
- Assignee: H. Lundbeck A/S
- Current Assignee: H. Lundbeck A/S
- Current Assignee Address: DK
- Agency: Wilmer Cutler Pickering Hale and Dorr LLP
- Main IPC: A61K31/497
- IPC: A61K31/497 ; C07D295/00 ; C07D295/073 ; C07B59/00 ; C07D241/04 ; A61K31/451 ; A61K31/454 ; A61K31/4545 ; A61K31/495 ; A61K31/496 ; A61K31/519 ; A61K31/551 ; A61K31/554
Abstract:
The present invention relates to deuterated 1-piperazino-3-phenyl-indanes and salts thereof with activity at dopamine receptors D1 and D2 as well as the 5HT2 receptors in the central nervous system, to medicaments comprising such compounds as active ingredients, to the use of such compounds in the treatment of diseases in the central nervous system, and to methods of treatment comprising administration of such compounds.
Public/Granted literature
- US20130281436A1 DEUTERATED 1-PIPERAZINO-3-PHENYL INDANES FOR TREATMENT OF SCHIZOPHRENIA Public/Granted day:2013-10-24
Information query
IPC分类:
